Related Experiment Video

Updated: Dec 13, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.8K

MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway

X-D Li1, X-M Li, J-W Gu

  • 1Dental Department, Yan'an People's Hospital of Shaanxi Province, Yan'an, Shaanxi, China.

European Review for Medical and Pharmacological Sciences
|August 4, 2020
PubMed

Insights

This study on miR-155's role in lymphoma has been withdrawn due to suspected research misconduct. The publisher retracted the article after authors failed to verify data originality.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • MicroRNAs (miRNAs) play crucial roles in cellular processes.
  • Dysregulation of miRNAs is implicated in various cancers, including lymphoma.
  • The JAK-STAT3 signaling pathway is frequently activated in lymphoma.

Purpose of the Study:

  • To investigate the role of microRNA-155 (miR-155) in regulating lymphoma cell proliferation and apoptosis.
  • To explore the potential molecular targets of miR-155 within the SOCS3/JAK-STAT3 signaling pathway.

Main Methods:

  • The study aimed to analyze the expression and function of miR-155 in lymphoma cells.
  • Investigated the interaction between miR-155, Suppressor of Cytokine Signaling 3 (SOCS3), and the Janus Kinase (JAK)/Signal Transducer and Activator of Transcription 3 (STAT3) pathway.
  • Utilized cell culture and molecular biology techniques to assess proliferation and apoptosis.

Main Results:

  • The article reported that miR-155 positively regulated lymphoma cell proliferation.
  • It was suggested that miR-155 induced apoptosis by targeting SOCS3.
  • The findings indicated miR-155's influence on the SOCS3/JAK-STAT3 pathway.

Conclusions:

  • The study concluded that miR-155 is a key regulator of lymphoma cell behavior.
  • The findings suggested a therapeutic potential for targeting the miR-155/SOCS3/JAK-STAT3 axis in lymphoma treatment.

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.8K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

661

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.0K